Home

Publications and Abstracts


FGCRT

1. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. Controlled Clin Trials 13:22-39, 1992.

2. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. New Eng J Med 326:213-220, 1992.*

3. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Foscarnet-Ganciclovir CMV Retinitis Trial: 4. Visual outcomes. Ophthalmology 101:1250-1261, 1994.

4. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Int Med 155:65-74, 1995.

5. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS Clinical Trials Group: Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 172:613-621, 1995.

6. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Assessment of cytomegalovirus retinitis: clinical evaluation vs centralized grading of fundus photographs. Arch Ophthalmol 114:791-805, 1996.

7. Wu AW, Coleson LC, Holbrook JT, Jabs DA for the Studies of Ocular Complication of AIDS Research Group: Measuring visual function and quality of life in patients with cytomegalovirus retinitis: Development of a questionnaire. Arch Ophthalmol 114:841-847, 1996.

8. Studies of the Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Clinical vs. photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Arch Ophthalmol 114:848-855, 1996.

9. Studies of Ocular Complications of AIDS in collaboration with the AIDS Clinical Trials Group: Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. J Infect Dis 176:50-58, 1997.

10. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol 124:141-157, 1997.

11. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol 124:141-157, 1997.

12. Wu AW, Revicki DA, Jacobson D, Malitz FE: Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Res 6: 481-493, 1997.

13. Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert CL and Reshef DS for the Studies of Ocular Complications of AIDS Research Group: Risk factors for advancement of cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 118:1196-1204, 2000.


CRRT

1. Studies of the Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Combination foscarnet and ganciclovir therapy vs. monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The Cytomegalovirus Retreatment Trial. Arch Ophthalmol 114: 23-33, 1996.*

2. Martin BK, Gilpin AMK, Jabs DA, and Wu AW for the Studies of Ocular Complications of AIDS Research Group: Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54:376-386, 2001

Back to TOP of page


HPCRT

1. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC Peripheral Cytomegalovirus Retinitis Trial. A randomized, controlled trial. Ann Intern Med 126:264-274, 1997.*

2. Jabs DA, Meinert CL, Lalezari JP: Letter to the Editor (response) regarding cidofovir for cytomegalovirus retinitis (HPCRT). Ann Int Med 127:490-491, 1997.

3. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: The HPMPC Peripheral Cytomegalovirus Retinitis Trial. AIDS 14:1571-1581, 2000.

Back to TOP of page


MACRT

1. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Monoclonal Antibody Cytomegalovirus Retinitis Trial. Arch Ophthalmol 115:1528-1536, 1997.*

2. Jabs DA, Kaplan Gilpin AM, Min YI, Erice A, Kempen JH and Quinn TC for the Studies of Ocular Complications of AIDS Research Group: HIV and CMV viral load and clinical outcomes in patients with AIDS and cytomegalovirus retinitis: The Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 16: 877-887, 2002.

3. Davidson M, Min Y, Holbrook JT, Quinn T, Murphy R, Jabs DA, Jacobson M, and Meinert CL for the Studies of Ocular Complications of AIDS Research Group: The Influence of filgrastim (granulocyte colony-stimulating factor on human immunodeficiency virus type 1 RNA in patients with cytopmegalovirus retinitis. J Inf Dis 186:1013-8, 2002.

4. Gilpin AM, Holbrook JT, Jabs DA, Meinert CL for the Studies of Ocular Complications of AIDS Research Group: Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Controlled Clinical Trials, 24(1):92-98, 2003.

Back to TOP of page


GCCRT

1. The Studies of Ocular Complications of AIDS Research Group (SOCA) in collaboration with the AIDS Clinical Trials Group: The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir CMV Retinitis Trial. Am J Ophthalmol 131:457-467, 2001.*

2. Dunn JP, Heinemann M-H, Jabs DA, Kuppermann B, Martin D Van Natta ML, and Zong A for the Studies of Ocular Complications of AIDS Research Group.  Complications of Ganciclovir implant surgery in patients with CMV retinitis. Retina 24 (1): 41-50, 2004.


LSOCA

1. Jabs DA, Van Natta ML, Kempen JH, Pavan PR, Lim J, Murphy R, Hubbard L for the Studies of Ocular Complications of AIDS Research Group: Characteristics of patients with CMV retinitis in the era of highly active anti-retroviral therapy (HAART). Am J Ophthalmol 133: 48-61, 2002.*

2. Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group: The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy. Ophthalmology 110 (5), 2003.*

3. Marshall BC, Jacobson MA, Adler SP in collaboration with the Studies of Ocular Complications of AIDS Research Group. Avidity of Antibodies to Cytomegalovirus in HIV Seropositive Patients with and without CMV Retinitis. Viral Immunol. 17(1):101-8, 2004.

4. Jacobson MA, Maecker HT, Orr PL, D'Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM for the Adults AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group:  Results of a CMV-Specific CD8+/IFNγ+Cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis. J Infect Dis. 189: 1362-1373, 2004.


5. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV Meredith TA, Kuppermann BD, Sepkowitz K, Li HK for the Studies of Ocular Complications of AIDS Research Group.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.  Ophthalmology 111: 2224-2231. 2004.*
 
6. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK for the Studies of Ocular Complications of AIDS Research Group.  Course of cytomegalovirus retinitis in the era of highly active antiretorviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology 111: 2232-2239, 2004.*
 
7. Weinberg DV, Holbrook JT, Hubbard LD, Davis MD, Jabs DA, Holland GN for the Studies of Ocular Complications of AIDS Research Group. Clinician versus Reading Center Assessment of cytomegalovirus retinitis lesion size.  Ophthalmology 112: 559-566, 2005.*
 
8. Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL for the Studies of Ocular Complications of AIDS Research Group. Risk Factors for Mortality in Patients with AIDS in the era of HAART.  Ophthalmology 112: 771-779, 2005.*

9. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW; Ocular Complications of AIDS Research Group. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med. 24, 165 (19) :2229-2236, 2005.

10. Kempen JH, Min Y-I, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA for the Studies of Ocular Complications of AIDS Research Group. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 113(4): 684-694, 2006.*

11. Brown DM, Thorne JE, Foster GL, Duncan JL, Brune LM, Mũnana A, Meinert CL, Jabs DA for the Studies of Ocular Complications of AIDS Research Group: Factors affecting attrition of patients with AIDS. AIDS Care, 18(7): 821-829, 2006.*

12. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL for the Studies of Ocular Complications of AIDS (SOCA) Research Group. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy. Ophthalmology, 113(8): 1432-40, 2006.*

13. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL for the Studies of Ocular Complications of AIDS (SOCA) Research Group. Causes of visual acuity loss among patients with AIDS and CMV in the era of HAART. Ophthalmology, 113:1441-1445, 2006.*

14. Shah KH, Holland GH, Yu F, Van Natta M, Nusinowitz S, in collaboration with the Studies of Ocular complications of AIDS (SOCA) Research Group. Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy. Am J Ophthalmol, 142: 284-292, 2006.

15. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Van Natta ML, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA; Studies of Ocular Complications of AIDS Research Group. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon-gamma and interleukin-2 and have a CD8+ cell early maturation phenotype. J Infect Dis. 194(11): 1537-46, 2006.

16. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL, for the Ocular Complications of AIDS Research Group. The effect of cytomegalovirus (CMV) retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology, 114:591-598, 2007.*

17. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of the Ocular Complications of AIDS Research Group. The Longitudinal Study of the Ocular Complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 114: 780-786, 2007.

18. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of the Ocular Complications of AIDS Research Group. The Longitudinal Study of the Ocular Complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 114: 787-793, 2007.

19. Jacobson, MA, Tan QX, Girling V. Poon C, Van Natta ML, Jabs DA, Inokuma M, Maecker HT, Bredt B, and Sinclair E, for the Studies of Ocular Complications of AIDS Research Group. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis 46:458-466, 2008.

20. Freeman WR, Van Natta ML, Jabs DA, Sample PA, Sadun AA, Thorne J, Shah KH, Holland GN for the SOCA Research Group. Vision function in HIV-infected individuals without retinitis; Report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol 45:453-462, 2008.

21. Jabs DA, for the Studies of Ocular Complications of AIDS Research Group. AIDS and ophthalmology, 2008. Arch Ophthalmol 126:1143-1146, 2008.


SOCA

1. Holbrook JT, Meinert CL, Van Natta ML, Davis MD, Hubbard L, Jabs DA for the Studies of Ocular Complications of AIDS Research Group: Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. Arch Ophthalmol 119:554-563, 2001.

2. Holbrook JT, Meinert CL, Jabs DA for the Studies of Ocular Complications of AIDS Research Group: Patient notification and followup after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV Retinitis. Controlled Clin Trials 22:62-68, 2002.

3. Davidson M, Min Y, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, and Meinert CL for the Studies of Ocular Complications of AIDS Research Group: Use of filgrastim (G-CSF) as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. AIDS 16: 757-765, 2002.

4. Holbrook JT, Jabs DA, Lewis RA, Weinberg D, Davis MD, Friedberg D for the Studies of Ocular Complications of AIDS Research Group. Visual loss in patients with cytomegalovirus retinitis and AIDS before wide spread availability of highly active antiretroviral therapy. Arch Ophthalmol 121 (1): 99-107, 2003.
 

Back to TOP of page


Commissioned papers

1. Thorne JE: Longitudinal analysis of visual field loss in patients with CMV Retinitis. (LSOCA, commissioned Aug 03/recommissioned June 2006).

2. Holland GN: Chronic CMV reactivation and its relationship to the progression of CMV retinitis in patients with AIDS. (LSOCA, commissioned Nov 03).

3. Holland GN in collaboration with the Studies of Ocular Complications of AIDS Research Group: Factors related to cytomegalovirus retinitis lesion opacity. (SOCA Study Combination commissioned Nov 02).

4. Holbrook JT: Evaluation of CMV retinitis treatment guidelines on mortality and visual function in the LSOCA Cohort. (LSOCA, commissioned Jul 05).

5. Kempen JH: Risk of cataract in patients with AIDS. (LSOCA, commissioned Sep 05).

6. 
Holland GN: Longitudinal study of contrast sensitivity among individuals with AIDS but no retinal infections. (commissioned Dec 06).

Back to TOP of page


Other Publications

These books are available at http://www.amazon.com

Clinical Trials Dictionary: Terminology and Usage Recommendations.  Meinert, CL. Baltimore, MD 1996.

Clinical Trials: Design, Conduct, and Analysis. Meinert, CL. New York, 1986.

Clinical Trials: A Methodologic Perspective. Piantadosi, S. New York, 1997.
 

Back to TOP of page

 

*Data are available upon request following review and approval by SOCA

Last updated Tuesday, June 16, 2009